Bridging the Gap: Index Volume [International Conference on AIDS (12th: 1998: Geneva, Switzerland)]

12th World AIDS Conference

cytokine * data 45

SKeyword Abstr
s oultures/Chemotactic cytokines and their receptor expression in
ntibodies and type-1 IL-2 and IL-12/Glucocorticoid h
uction of type-1, type-2 and /-chemokines in HIV+ pati
IV RNA and levels of,chemokines and soluble factor
duction of chemotactic and immune function in children
h1 and Th2 stimulatory, IL-12 and IL4, on HIV-1 specific
neurons/Inflammatory and HIV-1 associated neurodeg
ction/Pro-inflammatory and insulin resistance in HIV inf
els of pro-inflammatory after pneumococcal immunizati
h pulmonary infections/ Cytological profile in bronchoalveolar lava: A clinical, histological, cytological and immunohistochemical stu
ments of HIV-1-specific cytolytic T lymphocyte activity using froze
rence of CMV disease/ Cytomegalovirus (CMV) blood dissemina
and laboratory findings/ encephalitis in eight pat
s without CMV disease/ (CMV) in the cerebrospi
n HIV-infected women/ and herpes simplex viru
n HIV-infected patients/ screening in HIV-infect
f HIV-positive patients/ (CMV) DNA detection u
ar inoculation of human cytomegalovirus (CMV)/Long-term obse
sappearance of human (HCMV) in blood of AID
RT/Predictive value of (CMV)-PCR and pp-65 f
ong lasting remission of retinitis (CMV-R) withou
V-infected patients with (CMV) retinitis/Gancicl
DS patients/The role of (CMV)-Antigenemia as
he detection of plasma (CMV) DNA and CMV re
maintenance therapy of (CMV) retinitis: Experie
lian AIDS patients with retinitis (CMV-R)/HLA c
rization in a patient with retinitis/Extensive optic
nts expressing human UL97 genes from GCV-r
ovir therapy/Kinetics of in vivo in HIV infected p
disease/Distribution of (CMV) envelope glycop
s/Incidence of resistant (CMV) in patients being
or retinal detachment in retinitis/Laser photocoa
ion for the treatment of retinitis (CMV-R) in a da
in Tunisia/Detection of (CMV) DNA among imu
herapy for treatment of infection/The safety of c
mine the prevalence of retinitis in the age of HA
zone-derivatives inhibit replication in human cell
rted vision measures in retinitis and AIDS/Resp
mparison between flow cytometric and manual staining, microsco
nses measured by flow cytometry in HIV-1-infected subjects/CM
A new approach to flow based CD4 T-cell enumeration
Ils phenotyping by flow: A quality assurance programm
d by zymmune and flow methods/Comparison between
ease may play a role in cytopathogenesis and the development o
leucoplakia/Diagnosis cytopathologic of sub-clinical hairy leuco
n cell tropism spectrum, cytopathology peculiarities and clinical fe
proteins/The role of the cytoskeleton of HIV-infected cells as the tr
1 reverse transcriptase/ Cytotoxic T lymphocytes (CTL) recognitio
ntiretroviral treatment/ T lymphocytes and viral load in
nt HIV-1 gag subtypes/ T lymphocytes (CTL) from HIVes: Role of HIV specific cytotoxic T lymphocytes/DNA vaccine en
y of multiple HIV CD8+ T cells epitopes/A polytope vac
ubtype E/HIV-specific T lymphocytes (CTLs) in Thai ex
rrelates/HIV-1 specific T-lymphocyte responses in unin
A-A11 HIV-1 subtype E T lymphocyte (CTL) epitopes ide
and Thais/Cross-clade T cell response to HIV-1 protein
-2 elicits a Gag-specific T-cell response in juvenile but n
IV clades/HIV-specific T lymphocytes (CTL) in HIV-1 inf
ss-clade HIV-1 specific T lymphocyte (CTL) activity in HI
munization/SIV-specific T lymphocytes induced by DNA i
eath/Levels of specific T-cell (CTL) activity against HIVositive mothers/Strong T cell responses detected in the
0 cells/jiL/HIV-specific T lymphocytes in asymptomatic
Its/Anti-GM2 mediated antibody in HIV-infected adults/

act
21144
21160
220*/21170
21178
21190
31153
32200
32276
60488
60281
41167
31156
22248
22253
22262
32135
42420
60622
11231
14*/22237
22241
22244
22247
22251
22265
22270
22272
22273
31199
31202
31203
32233
32238
32244
60013
60195
60550
60651
60713
60416
31180
41116
42182
42193
21150
60514
21158
11137
31137
31138
31149
11240
21193
599*/31120
600*/31123
603*/31127
602*/31128
31129
604*/31132
31139
31145
31155
31157
31158
60458

- Keyword Abstra
ination with stavudine ( ) and lamivudine (3TC) in HIV patients
d, comparative study of + ddl + IDV versus ZDV + 3TC + IDV in
oing study/Stavudine ( ), didanosine (ddl), and nelfinavir comb
ontaining to stavudine ( )-containing regimens in the Pacific Oa
double therapy (ZDV/ + 3TC) vs triple therapy (d4T + 3TC + i
ine (ddl) ~ stavudine ( ) in high/low dose combinations in an a
GC) in combination with /DDC/MIKADO: Saquinavir soft gel ca
s RTV/SQV/stavudine ( ) (the Prometheus study): Preliminary r
of therapy/Stavudine ( ), nelfinavir (NFV) and nevirapine (NV
3TC), and stavudine ( )-didanosine (ddl) in healthy volunteer
ART (saquinavir-SGC, and ddC) initiation in previously untrea
es/ml)/Double (3TC + ) vs triple (3TC + d4T + saquinavir) ther
ombination stavudine ( ), didanosine (ddl) and nevirapine (NV
(3TC), and stavudine ( ) in therapy naive HIV-infected patients
ologic efficacy of 3TC + vs. 3TC + d4T + SQV in HIV-1 infected
t 72 weeks/Stavudine ( ), didanosine (ddl) and ritonavir as a tri
ZT + 3TC + indinavir vs + 3TC + indinavir for HIV infection in pr
domised clinical trial of + 3TC + SQV + NFV with or without int
s RTV/SQV/stavudine ( ) on cerebrospinal fluid (CSF) HIV-RN
esistance to stavudine ( ) after long-term monotherapy/Genoty
of therapeutic failure to /3TC combination/M184V mutation is
ession after 12 months/ plus 3TC or AZT plus 3TC - Viral load
r/stavudine (RTV/SQV/ ) in a randomized clinical trial: Prelimin
in patients treated with, ddl ~ hydroxyurea (HU)/Assessment
al effect of AZT versus in combination with 3TC and indinavir i
with ritonavir (RTV) and in patients with advanced HIV disease
nhibitor (PI) regimens ( +3TC+IDV vs. d4T+RTV+SQV) in preed patients treated with + 3TC + indinavir (IDV)/Long-term foil
T containing stavudine ( ), lamivudine (3TC) and saquinavir/Fat
herapies for HIV/AIDS/ DAAIR project to provide free, comprehen
cation (PHE) outreach/ Daily activity form as monitory tool for peer
stained efficacy of once daily administration of didanosine in combi
ea once daily/DDI once vs twice daily alone and also with hyd
s-study analysis/Once- dosing of nevirapine: A retrospective,
tween single and twice dosing of ganciclovir/Induction treat
kfurt HIV cohort/Once- therapy (NVP/ddl/3TC) for the IVDU
nfection taking a twice- clarithromycin regimen/Adherence p
experience with a once- dosing antiretroviral combination ther
kers/Safety of multiple applications of COL-1492, a nonoxyn
ddl and 3TC both once plus indinavir bid/Short-term efficacy
h clarithromycin 500 mg /MAC prophylaxis with clarithromycin
)/Bacterial vaginosis in Dakar (Senegal)/Bacterial vaginosis in
n Senegal. Enda sante,, Senegal/A community based appr
enegal: Enda Sante,, Senegal/A community based appr
n an illeterate suburb of: Successes and constraints/The ex
on among prostitutes in /Experimental activity of reconversi
ale population/Project DALIA: Women at workplace - Information
Is/Either mithocondrial damage or Fas activation mediate apoptos
t. Petersburg/Study of dangerous behavioral patterns in teenage
istrict/Communicating dangers of HIV infection among illiterate m
sease progression in a Danish cohort of HIV infected individuals/
al of cotrimoxazole and dapsone-pyrimethamine for primary prop
hort of police officers in Dar es Salaam, Tanzania/Incidence of HI
d probability sample of es Salaam, Tanzania: Results from the
al STD clinic for them in es Salaam: A preliminary report/Unus
educators experience in es Salaam, Tanzania outreach progra
er 1997/HIV-2 in Spain: Data from the National Registry up to Dece
ntiretroviral treatment. from the Eurosida study group/Regio
ombination treatment: on 4230 patients in the Italian cohort
997/HTLV-I in Spain: from the National Registry up to Dece
who have sex with men: from California test sites/HIV risk fact
xually active women - from a national (US) survey of reprod
mmunication strategy/ organizing and IEC development for
r health care providers: from six years' experience/HIV telep
n HIV-infected children: from Department of Infectious Diseas
cal transmission of HIV: from Department of Infectious Diseas
he result of an HIV test: from the US National Health Interview
ent of HIV/AIDS today/ as a tool in surveillance, programme
ce, clinical and autopsy data in Abidjan, C6te d'lvoire/Clinical mani
S diagnosis in Germany from the German AIDS register/Freq
of personal and clinical on HIV patients diagnosed in a hospit
al HIV Test Surveillance, 1985-1996/HIV in Canada: National
itro and epidemiologic on the role of heroin on CD4+ decline i

ty influences on survey /How reliable are sexual behavior self
to ensure the quality of /Involving the target population in carr
ry and socio-economic on quality of life (QoL) in HIV infected
based seroprevalence in California/Estimate of HIV incidenc
nfection/EEG charting in CNS disorders evaluation in patient
ries using surveillance /Evaluation of STD care based on the
client-centred program /Measuring impact and evaluating eff,ct
12224
12225
12226
12228
12238
12241
12244
291*/12274
12275
12374
21123
22344
22357
22371
22376
22401
22403
22414
32197
32285
32310
32321
32362
289*/41142
42169
60714
60791
60875
60998
60593
33591
12351
12352
12360
22267
22398
32324
32393
33145
60678
60716
13285
13431
33312
43188
60265
60494
21166
28*/14258
60155
13327
22181
13108
13116
22203
33351
11207
437*/12272
12312
13300
23121
33106
33501
42406
60304
60305
60354
60594
12146
13188
13201
13228
13334

14102
14349
14351
23490
32226
33233
34153

quired for specific T-cell cytotoxicity /New anti-HIV function: RAN 31148
ody-dependent cellular (ADCC) in HIV-1 infected pati 31152
nsmitted diseases in the Czech Republic/Trends in sexually transm 13287
HIV/AIDS spread in the Republic/Changing patterns of HIV 13354
ducation teachers in the Republic/AIDS related knowledge 13520
g drug users in Prague, Republic 1996-1997/High rate of H 23197
ing sex with men in the Republic/Knowledge and use of saf 43324
populations at risk in the and Slovak Republics/Testing urin 60295
ed HIV prevention in the Republic/Comprehensive and dive 60442
HIV transmission in the Republic/Mother-to-child HIV trans 60454
deoxy-5-fluorocytidine ( D-D4FC )/Anti-HIV activity, biochemistry, a 557*/41174
AZT/3TC vs alternating d4T/ddl and AZT/3TC vs d4T/ddl/ALBI (A 12227
T-naive HIV+ patients?/ plus hydroxyurea: An alternative t 32315
stant HIV infection with d4T /3TC/hydroxyurea/Salvage of multi-dr 288*/12205
d, comparative study of + 3TC + IDV versus ZDV + 3TC + IDV i 12223